Genel Üroloji ile İlgili Sendromlar – 2
Özet
Ürolojik sendromlar, genetik ve gelişimsel bozukluklara bağlı böbrek ve üriner sistem anomalileriyle seyreden, multidisipliner yaklaşım gerektiren klinik tablolardır. Aşırı Aktif Mesane (AAM), detrusor kasının düzensiz kasılmaları sonucu idrar sıkışması, sık idrara çıkma ve nokturi ile karakterizedir ve yaşam kalitesini olumsuz etkiler. Tanı, kapsamlı anamnez, fizik muayene ve diğer nörojenik veya ürotelyal patolojilerin dışlanmasıyla konur; tedavi davranışsal önlemler, farmakoterapi, minimal invaziv yöntemler ve cerrahiyi içerir.Nadir genetik sendromlar ürolojik komplikasyonlar açısından kritik öneme sahiptir: Menkes hastalığında mesane divertikülleri ve duvar zayıflığı; Williams sendromunda konjenital böbrek anomalileri ve mesane disfonksiyonu; Ehlers-Danlos sendromunda vajinal prolapsus, mesane disfonksiyonu ve tekrarlayan idrar yolu enfeksiyonları; Lesch-Nyhan sendromunda hiperürisemiye bağlı nefrolitiyazis ve tofüs; Zinner sendromunda tek taraflı böbrek agenezisi ve seminal vezikül kisti gözlenir. Erken tanı ve multidisipliner yönetim, komplikasyonların önlenmesi ve yaşam kalitesinin korunması açısından kritik önemdedir.
Referanslar
Hutchinson A, Nesbitt A, Joshi A, Clubb A, Perera M. Overactive bladder syndrome: Management and treatment options. Aust J Gen Pract. 2020;49(9):593-8.
Wolff GF, Kuchel GA, Smith PP. Overactive bladder in the vulnerable elderly. Res Rep Urol. 2014;6:131-8.
Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology. 2004;64(6 Suppl 1):2-6.
Arnold J, McLeod N, Thani-Gasalam R, Rashid P. Overactive bladder syndrome - management and treatment options. Aust Fam Physician. 2012;41(11):878-83.
Ngo B, Papa N, Perera M, Bolton D, Sengupta S. Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria. BJU Int. 2017;119 Suppl 5:19-25.
Ngo B, Perera M, Papa N, Bolton D, Sengupta S. Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review. BJU Int. 2017;119 Suppl 5:10-8.
Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558-63.
Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572-80.
Castro RA, Arruda RM, Zanetti MR, Santos PD, Sartori MG, Girão MJ. Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics (Sao Paulo). 2008;63(4):465-72.
Willis-Gray MG, Dieter AA, Geller EJ. Evaluation and management of overactive bladder: strategies for optimizing care. Res Rep Urol. 2016;8:113-22.
Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, et al. Appendix: Executive summary of CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017;11(5):E248-e9.
Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017;11(5):E142-e73.
Hsu FC, Weeks CE, Selph SS, Blazina I, Holmes RS, McDonagh MS. Updating the evidence on drugs to treat overactive bladder: a systematic review. Int Urogynecol J. 2019;30(10):1603-17.
Sukhu T, Kennelly MJ, Kurpad R. Sacral neuromodulation in overactive bladder: a review and current perspectives. Res Rep Urol. 2016;8:193-9.
Çetinel B, Kocjancic E, Demirdağ Ç. Augmentation cystoplasty in neurogenic bladder. Investig Clin Urol. 2016;57(5):316-23.
English SF. Update on voiding dysfunction managed with suprapubic catheterization. Transl Androl Urol. 2017;6(Suppl 2):S180-s5.
Tümer Z, Møller LB. Menkes disease. European Journal of Human Genetics. 2010;18(5):511-8.
Horn N, Tümer Z. Menkes disease and the occipital horn syndrome. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. 2002:651-85.
Culotta VC, Yang M, O'Halloran TV. Activation of superoxide dismutases: putting the metal to the pedal. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2006;1763(7):747-58.
Turski ML, Thiele DJ. New roles for copper metabolism in cell proliferation, signaling, and disease. Journal of Biological Chemistry. 2009;284(2):717-21.
Camakaris J, Petris MJ, Bailey L, Shen P, Lockhart P, Glover TW, et al. Gene amplification of the Menkes (MNK; ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux. Human Molecular Genetics. 1995;4(11):2117-23.
Monty J-F, Llanos RM, Mercer JF, Kramer DR. Copper exposure induces trafficking of the menkes protein in intestinal epithelium of ATP7A transgenic mice. The Journal of nutrition. 2005;135(12):2762-6.
Waz WR, Lee TM, Niaudet P. Williams syndrome. UpToDate TePas E (ed): Wolters Kluwer, Waltham, WA. 2021.
Pankau R, Partsch CJ, Winter M, Gosch A, Wessel A. Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome. Am J Med Genet. 1996;63(1):301-4.
Pober BR, Lacro RV, Rice C, Mandell V, Teele RL. Renal findings in 40 individuals with Williams syndrome. Am J Med Genet. 1993;46(3):271-4.
Sammour ZM, Gomes CM, Duarte RJ, Trigo-Rocha FE, Srougi M. Voiding dysfunction and the Williams-Beuren syndrome: a clinical and urodynamic investigation. J Urol. 2006;175(4):1472-6.
Morris CA, Braddock SR. Health Care Supervision for Children With Williams Syndrome. Pediatrics. 2020;145(2).
Bird LM, Billman GF, Lacro RV, Spicer RL, Jariwala LK, Hoyme HE, et al. Sudden death in Williams syndrome: report of ten cases. J Pediatr. 1996;129(6):926-31.
Sindhar S, Lugo M, Levin MD, Danback JR, Brink BD, Yu E, et al. Hypercalcemia in Patients with Williams-Beuren Syndrome. J Pediatr. 2016;178:254-60.e4.
Partsch CJ, Japing I, Siebert R, Gosch A, Wessel A, Sippell WG, et al. Central precocious puberty in girls with Williams syndrome. J Pediatr. 2002;141(3):441-4.
Martin ND, Smith WR, Cole TJ, Preece MA. New height, weight and head circumference charts for British children with Williams syndrome. Arch Dis Child. 2007;92(7):598-601.
Sammour ZM, Gomes CM, de Bessa J, Jr., Pinheiro MS, Kim CA, Honjo RS, et al. The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome. J Urol. 2012;188(1):253-7.
Leganger J, Søborg ML, Farholt S, Lund AM, Rosenberg J, Burcharth J. [Ehlers-Danlos syndrome]. Ugeskr Laeger. 2016;178(17).
Malfait F, De Paepe A. The ehlers-danlos syndrome. Progress in heritable soft connective tissue diseases. 2013:129-43.
Nanagiri A, Shabbir N. Lesch-Nyhan Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet journal of rare diseases. 2007;2(1):48.
Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007;56(9):1179-86.
Brock WA, Golden J, Kaplan GW. Xanthine calculi in the Lesch-Nyhan syndrome. The Journal of Urology. 1983;130(1):157-9.
Abakar D, Badi FE, Sabiri M, El Manjra S, Lezar S, Essodegui F. Zinner Syndrome. Eur J Case Rep Intern Med. 2021;8(7):002628.
Kamalov AA, Karpov VK, Pshihachev AM, Andreytsev IL, Takhirzade TB, Ekhoyan MM, et al. [Surgical treatment of Zinner syndrome]. Urologiia. 2022(4):60-2.
Radhia S, Samira F, Mounir T, Hamadi S. [Seminal vesicle cyst associated with renal agenesis and ipsilateral ectopic ureter. Report of a case]. Ann Urol (Paris). 2002;36(6):381-3.
